Clinical Trial Update: A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of an investigational medication for secondary hyperparathyroidism in patients on dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperparathyroidism

Snippet

Sponsor: Amgen | Conditions: Secondary Hyperparathyroidism, End Stage Renal Disease | Phase 3 | Status: COMPLETED